Navigation Links
Medivation to Present at 8th Annual Needham Life Sciences Conference
Date:6/4/2009

SAN FRANCISCO, June 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, at 10:30 a.m. Eastern Time at the New York Palace Hotel.

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

A live audio webcast of the corporate presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program that includes several Phase 3 trials assessing the efficacy and safety of Dimebon taken alone or in combination with other Alzheimer's medication in patients with mild, moderate or severe Alzheimer's disease. Further development of Dimebon in patients with Huntington's disease is also planned. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castrati
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medivation Announces Offering of 2,750,000 Shares of Common Stock
2. Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
3. Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
4. Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
5. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
6. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
7. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
8. Medivation Announces Participation in Upcoming Conferences
9. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
10. Medivation Announces Participation in Upcoming Conferences
11. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Could genetic code determine someone’s ... study by researchers at the Harvard T.H. Chan ... support of the Coffee and Caffeine Genetics Consortium and ... past fall, the study—one of several recent HSPH investigations ... from more than 120,000 regular coffee drinkers of European ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared ... UniWigs during the Easter Holidays from today until April ... April Fools’ Day. , As the winter fades and ... Easter Festival, with religious origins to countries in Europe ... Christmas. The best wig provider, UniWigs, would like to ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple teams ... according to new research released today at the American Orthopaedic ... “Our findings indicate that a 10 inch increase in height ... history of injury, a 10 mile per hour increase in ... history of injury, and playing for more than one team ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... The "Petrick Sustainable Health System" ... 18 years of research and experience with patients from ... Jon Petrick is excited to be launching his breakthrough ... immediate benefits of this radical new system are increased ... of the immune system, faster healing of injuries, rapid ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... some forms of plankton and bacteria to build an extra ... University of Warwick to devise a startlingly simple way to ... liquid) their own armoured protection. The Warwick researchers ... variety of nanoparticles opening a new strategy in the design ...
... important protein, produced naturally inside cells, that appears to ... laboratory. The findings, published tomorrow in the journal ... new treatments. Prostate cancer is the most common ... diagnosed with the disease every year. Many prostate cancers ...
... surgery have long been considered to be at low ... emerged as an increasingly frequent and potentially fatal complication ... January 21, 2011 in the World Journal of ... new light on this discrepancy by reporting two patients ...
... in German . Nearly ten percent ... patients do not respond to any established treatment method. Targeted ... "brain pacemaker" has recently raised hopes: According to initial studies, ... this manner see a significant improvement in mood. Physicians from ...
... Milan, Italy, 31 January 2010 Wouldn,t life be easy ... are able to adapt to the unexpected using an inbuilt ... those predictions turn out. An area at the front of ... and studies have shown that patients with damage to this ...
... 29 (HealthDay News) -- An advisory panel to the ... electroconvulsive (also known as "electroshock") devices should be subject ... entering the market. The much-awaited decision is ... psychiatric treatment, which some patients see as doing great ...
Cached Medicine News:Health News:Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles 2Health News:Scientists find key protein that suppresses prostate cancer growth in the laboratory 2Health News:Brain pacemakers: A long-lasting solution in the fight against depression 2Health News:Brain pacemakers: A long-lasting solution in the fight against depression 3Health News:Revealing the wiring that allows us to adapt to the unexpected 2Health News:FDA Panel Recommends Testing of Electroshock Devices 2Health News:FDA Panel Recommends Testing of Electroshock Devices 3Health News:FDA Panel Recommends Testing of Electroshock Devices 4
(Date:3/27/2015)... WINNIPEG , March 27, 2015 /PRNewswire/ - Medicure ... Board of Directors has approved the grant of an ... management company employees and consultants of the Company pursuant ... 181,070 are set to expire on the tenth anniversary ... expire on the third anniversary of the date of ...
(Date:3/27/2015)... 27, 2015 /CNW Telbec/ - Russell Williams , ... Companies (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the ... on the biopharmaceutical industry. However, the association is concerned ... "We commend the government,s intent to strive for a ... to promote Quebec,s economic development ...
(Date:3/27/2015)... 27, 2015 Biopharmaceutical Industry Leads Manufacturing ... comes out on top as the country,s manufacturing leader ... report  from ndp│analytics. According to the  analysis , the ... over the last decade, accounting for 27 percent of ... A Short Video on Medicare Part D ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: